Granalix BioTechnologies Overview
Granalix BioTechnologies was established to develop innovative, science-based formulations of natural antioxidants that can be used for the prevention and treatment of neurodegenerative conditions. The company's first product, GranaGard, is a submicron self-emulsion formulation of pomegranate seed oil, which contains high concentrations of punicic acid (PA), one of the strongest natural antioxidants. In the GranaGard formulation, PA has been shown to convert in vivo into conjugated linoleic acid, an established neuroprotector and mitochondrial activity modulator. GranaGard was shown to delay disease onset in a mouse model of genetic prion disease, which presents neurodegenerative features reminiscent of Alzheimer's disease, as well as to reduce disease burden in a mouse model of multiple sclerosis. All components of GranaGard are generally regarded as safe by the FDA.
Latest News
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Mature |
| Rounds | 0 |
| Investors | 0 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | il.granalix.com |
| Careers | Careers page |
Locations
Yad Harutsim Street 6, Jerusalem, Israel
Photos & Videos
2 item(s)
Granalix BioTechnologies Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesHealthcarePatientsConsumersDemographics & FamilySeniorsCore Technology
BiologicalsHerbalsTags (6)
pharmaceuticalsmultiple-sclerosissupplementsbiotechnologychronic-patientspharma-companiesGeographic Markets
PortugalIsraelGreeceMexicoGlobalGranalix BioTechnologies Financials
Granalix BioTechnologies Lifecycle
Granalix BioTechnologies News
6 articlesGranalix BioTechnologies Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 9 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
Granalix BioTechnologies Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 91/100 |
| Missing | funding rounds, markets, not claimed |
| BI Verification | Natalia Golczar |
| Registrar ID | 514925205 |
| Crunchbase | granalix-bio-technologies |
| Last updater | Natasha Voloshin |
| Updater email | natashavolo@gmail.com |
| Last update | 2020-12-13T00:00:00.000Z |
| Created | 2016-07-20T00:00:00.000Z |